Skip to content
Peptigraph home

Ipamorelin

GHRP (ghrelin receptor agonist). Ipamorelin is Not FDA approved · research chemical; research-chemical versions are not the approved drug.

Also called:ipaipam
Medically reviewed by Juan Pablo Frías, MD · · DisclosureUpdated Strongest evidence: Human RCT evidence, 4 of 4
StatusNot FDA approved · research chemicalProhibited by WADA (S2.2.4)Full legal history

Key facts

How we verify
Class
GHRP (ghrelin receptor agonist)
Also called
ipa, ipam
Vial sizes sold
2 mg, 5 mg, 10 mg
Community-reported sizes
Half-life
2 hours terminal half-life
intravenous infusion (15 min), in people · Pharmaceutical research 1999, PMID 10496658
FDA status
Not FDA approved · research chemical
No approved product found
WADA
Prohibited (S2.2.4)
In and out of competition
Everything on Ipamorelin

Ipamorelin guides

DosageDoses used in published studies, with the source for each.Side effectsWhat labels and studies report, and what is unknown.CalculatorVial, water and dose to syringe units.Legal statusFDA, compounding and WADA status with dates.For menopauseWhat research says about Ipamorelin for menopause.

Evidence at a glance

Human and animal counts are PubMed records from our evidence ledger (search counts, not studies we reviewed). The grade is the strongest design among the studies we summarised for that goal: a human randomized trial outweighs any number of animal studies.

Ipamorelin: studies by condition
ConditionHuman studiesAnimal studiesStudies we summarisedEvidence grade
Menopause000No graded study for this goal

Grades follow our evidence scale. Summarised studies come from our evidence file, each quote checked against the abstract or label.

Compared with

IpamorelinvsTesamorelinGHRP (ghrelin receptor agonist) next to ghrh analog: evidence, dosing and legal status side by side.FDA approved (Egrifta)Read the comparison →IpamorelinvsSermorelinGHRP (ghrelin receptor agonist) next to ghrh analog: evidence, dosing and legal status side by side.Compounded by prescriptionRead the comparison →IpamorelinvsCJC-1295GHRP (ghrelin receptor agonist) next to ghrh analog: evidence, dosing and legal status side by side.Not FDA approved · research chemicalRead the comparison →

Common stacks

Ipamorelin is often sold pre-mixed or combined with other peptides. No controlled study has tested these combinations; the pages below cover the math and what each part has been studied for.

CJC-1295 + IpamorelinCJC-1295 (no DAC) and Ipamorelin10 mg blendsBlend calculator
Tesamorelin + IpamorelinTesamorelin and Ipamorelin
Sermorelin + IpamorelinSermorelin and Ipamorelin
Ipamorelin + TesamorelinIpamorelin + SermorelinIpamorelin + BPC-157Ipamorelin + Tirzepatide

Common questions

Is Ipamorelin FDA approved?

Ipamorelin is Not FDA approved · research chemical. Products sold as research chemicals are not the approved drug and are not checked by the FDA.

Is Ipamorelin banned in sport?

Yes. Prohibited by WADA (S2.2.4), so it is prohibited at all times for tested athletes.

How much water goes in a 10 mg vial?

That choice only changes the concentration. With 2 mL, the vial is 5 mg/mL. The calculator converts any amount to syringe units. It does the math only and does not suggest a dose.

Sources

  1. 1US search volume and year-over-year trend, Google Keyword Planner export (Jun–Aug 2026 vs 2025)Peptigraph research · 2026peptigraph.com/methodology/Accessed 1 Oct 2026
  2. 2World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
  3. 3United States: No FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "ipamorelin" returned no matches on 2 Oct 2026.U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
  4. 4US compounding: Ipamorelin acetate is in FDA's 503B category 2 (added 29 September 2023).U.S. Food and Drug Administration · 2026fda.govAccessed 2 Oct 2026
  5. 5FDA warning letters to five research-peptide sellersFDA warning letter (NuScience Peptides; 1 of 5) · 2026fda.govAccessed 2 Oct 2026
  6. 6Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients.International journal of colorectal disease · 2014PMID 25331030Accessed 2 Oct 2026
  7. 7Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers.Pharmaceutical research · 1999PMID 10496658Accessed 2 Oct 2026
  8. 8PubMed search: ipamorelin[tiab] (50 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  9. 9PubMed search: ipamorelin[tiab] AND (half-life[tiab] OR pharmacokinetic*[tiab]) (4 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026

Found an error? Report a correction.